Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Journal of Pediatric Orthopedics|December 25, 2002
Pulsed color-flow Doppler analysis of arterial deficiency in idiopathic clubfootDanielle A Katz, Eileen L Albanese, E Mark Levinsohn, et al.
Biomolecules|May 27, 2023
A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative DisordersKatherine O Kopp, Margaret E Greer, Elliot J Glotfelty, et al.
Molecular Cancer Therapeutics|August 14, 2015
Anticancer Properties of a Novel Class of Tetrafluorinated Thalidomide AnaloguesShaunna L Beedie, Cody J Peer, Steven Pisle, et al.
Biochemical and Biophysical Research Communications|August 3, 2025
Monoterpenoid fluorophthalimide IMiDs that lack human cereblon binding: synthesis and anti-proliferative, anti-angiogenic and anti-inflammatory activitiesWeiming Luo, Kathleen M Garchitorena, David Tweedie, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2010
Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growthKhuloud T Al-Jamal, Wafa' T Al-Jamal, Simon Akerman, et al.
Molecules (Basel, Switzerland)|December 5, 2020
Antiangiogenic Activity and in Silico Cereblon Binding Analysis of Novel Thalidomide AnalogsMegan L Peach, Shaunna L Beedie, Cindy H Chau, et al.
Journal of Biomedical Science|March 5, 2023
Novel, thalidomide-like, non-cereblon binding drug tetrafluorobornylphthalimide mitigates inflammation and brain injuryDaniela Lecca, Shih-Chang Hsueh, Weiming Luo, et al.
Stem Cells (Dayton, Ohio)|June 8, 2017
Common and Distinctive Functions of the Hippo Effectors Taz and Yap in Skeletal Muscle Stem Cell FunctionCongshan Sun, Vanessa De Mello, Abdalla Mohamed, et al.
Development (Cambridge, England)|February 14, 2018
The developmental and genetic basis of 'clubfoot' in the peroneal muscular atrophy mutant mouseJ Martin Collinson, Nils O Lindström, Carlos Neves, et al.
Pageof 7